With the ADC field continuing to grow, the demand for continuous innovation leaves a great opportunity to make your mark in the field with a novel approach to development. For this reason, biopharma and biotech are shifting attention to advanced target selection methods to source novel routes for ADC therapeutic activity.

The 4th ADC Target Selection Summit has been created for those professionals seeking to develop a first-in-class ADC through innovation in the target.

In an intimate and discussion-focused environment, hone into the complex mechanistic biology around the target to implement advanced computational approaches to screen potential targets, don’t miss this opportunity to place novel targeting as a high priority.

Event link here.